Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative

Journal of Periodontal Research

Volumn 41, Issue 4, 2006, Pages 273-279

  Itoh, N ^a   Kasai, H ^a   Ariyoshi, W ^a   Harada, E ^a   Yokota, M ^a   Nishihara, T ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Bone regeneration; Enamel matrix derivative; Osteoclast; Periodontitis

Indexed keywords

CARRIER PROTEIN; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; METABOLISM; MONOCYTE; MOUSE; MOUSE STRAIN; OSTEOCLAST; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE REGENERATION; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DENTAL ENAMEL PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MONOCYTES; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 33748520592     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00868.x     Document Type: Article

References (31)

1. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodonlol 1997:24:658-668.
2. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
3. Gestrelius S, Andersson C, Johansson C, Persson E, Brodin A, Rydheg L, Hammerström L. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontal 1997;24:678-684.
4. Gestrelius S, Andersson C, Lindstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997:24:685-692.
5. Schwartz Z, Carnes L Jr, Pulian R. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000;71:1287-1296.
6. Tokiyasu Y, Takata T, Saygin E, Somerman M. Enamel factors regulate expression of genes associated with cementoblasts. J Periodontol 2000:71:1829-1839.
7. Sculean A, Reich E, Chiantella GC, Brecx M. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases. Int J Periodontics Restor Dent 1999;19:157-163.
8. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restor Dent 1999;19:8-19.
9. American Society for Bone and Mineral Research President's Committee on Nomenclature. Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. J Bone Miner Res 2000:15:2293-2296.
10. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-1508.
11. Otsuka T, Kasai H, Yamaguchi K, Nishihara T. Enamel matrix derivative promotes osteoclast cell formation by RANKL production in mouse marrow cultures. J Dent 2005:33:744-755.
12. Hsu, J, Lacey L, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegrin ligand. Proc Nail Acad Sci USA 1999;96:3540-3545.
13. Anderson DM, Moraskovsky E, Billingsley WL et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
14. Darnay BG, Haridas V, Ni J, Moore A, Aggarwal BB. Characterization of the intracellular domain of receptor activator of NF-KB (RANK). J Biol Chem 1997:273:20551-20555.
15. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev 1999:20:345-357.
16. Nishida E, Gotoh H. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 1993;18:128-131.
17. Avruch J, Zhang XF, Kryakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 1994;19:279-283.
18. Davis J. MAPKs: new JNK expands the group. Trends Biochem Sci 1994;19:470-473.
19. Iwasaki S, Hattori A, Sato M, Tsujimoto M, Kohno N. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J Biol Chem 1996;271:17360-17365.
20. Iwasaki S, Iguchi M, Watanabe K, Koshino R, Tsujimoto M, Kohno M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by morphogenetic protein-2. J. Biol Chem 1999;274:26503-26510.
21. Schwenger P, Alpert D, Skolnik Y, Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salisylate leads to inhibition of tumor necrosis factorinduced kappaB alpha phosphorylation and degradation. Mol Cell Biol 1998;18: 78-84.
22. Cobb MH, Goldsmith EJ. How MAP kinase are regulated. J Biol Chem 1995;270:14843-14846.
23. Matsumoto M, Sudo T, Osada H, Tsujimoto M. Involvement of p38 mitogenactivated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Blol Chem 2000:275:31155-31161.
24. Takahashi N, Yamada H, Yoshikl S et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. J Endocrinol 1988;122:1373-1382.
25. Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T. Specific inhibitors of vacuolar H( + )-ATPase trigger apoptotic cell death of osteoclasts. J Bone Miner Res 1997;12:1116-1123.
26. Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluide from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-1352.
27. Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954:7:322-326.
28. Ariyoshi W, Takahashi T, Kanno T, Ichimiya H, Takano H, Koseki T. Mechanisms involved in enhancement of osteoclast formation and function by low-molecular weight hyaluronic acid. J Biol Chem 2005;280:18967-18972.
29. Iwata T, Morotomi Y, Tanabe T, Fukae M, Ishikawa I, Oida S. Noggin blocks osteoinductive activity of porcine enamel extracts. J Dent Res 2002;81:387-391.
30. Li J, Sarosi I, Van XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acatl Sci USA 2000:97:1566-1571.
31. Fuller K, Thong T, Breton BC, Chambers TJ. Automated three-dimensional characterization of osteoclastic resorption lacunae by stereoscopic scanning electron microscopy. J Bone Miner Res 1994;9:17-23.